2023
DOI: 10.1016/j.virol.2022.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Modeling senecavirus a replication in immortalized porcine alveolar macrophages triggers a robust interferon-mediated immune response that conversely constrains viral replication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 34 publications
0
0
0
Order By: Relevance
“…Extending this inquiry to other viral 3C-like proteases yielded a surprising result: none were capable of cleaving Pro-IL-1β. This specificity suggests that SVV 3C is currently the only viral protease capable of cleaving Pro-IL-1β, which explains why SVV infection causes a stronger inflammatory response [ 28 , 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Extending this inquiry to other viral 3C-like proteases yielded a surprising result: none were capable of cleaving Pro-IL-1β. This specificity suggests that SVV 3C is currently the only viral protease capable of cleaving Pro-IL-1β, which explains why SVV infection causes a stronger inflammatory response [ 28 , 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…SVA-eGFP constructed by our laboratory ( 52 ) was used to determine the effects of STAT1 and STAT2 mutants on SVA. In brief, HEK-293T cells were transfected with STAT1/STAT2 or its mutants for 24 h, and the cells were inoculated with SVA-eGFP at an MOI of 0.1 for 12 h. Fluorescent intensity of eGFP was measured and visualized by inverted fluorescence microscopy (10× magnification using EVOS5000).…”
Section: Methodsmentioning
confidence: 99%
“…However, there are compelling data that it can overcome immune checkpoint inhibitor (ICI) resistance (i.e., PD-1/PD-L1 and CTLA4 antibodies) in pancreatic cancer murine models, thereby converting immunologically "cold" tumors via systemic anti-tumor immune responses with increased T-cell infiltration [35,36]. It had previously been shown to colonize porcine macrophage PAM-Tang [37] and 3D4/21 [38] cell lines.…”
Section: Pre-clinical Datamentioning
confidence: 99%